David G. Pfister

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma”.

Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

Journal of Clinical Oncology(2024)10.1200/jco.23.01308

N/A

1.9DataRank · unranked

94 citations

Eric J. Sherman, Heiko Schöder, Rick Wray, Jay O. Boyle, Bhuvanesh Singh +37 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)

Cancer(2023)10.1002/cncr.35103

N/A

0.481DataRank · unranked

12 citations

Nathan R. Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R. Antonescu, Gary Patrick Frenette +4 more

The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6019

N/A

0DataRank · unranked

14 citations

Eric J. Sherman, Heiko Schöder, Sean M. McBride, Yao Yu, Jung Julie Kang +15 more

Postoperative PET/CT for detection of early recurrence (ER) after surgery for squamous cell carcinomas (SCC) of the oral cavity (OC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6060

N/A

0DataRank · unranked

1 citations

Heiko Schöder, Jung Julie Kang, Sean M. McBride, C. Jillian Tsai, Linda Chen +15 more

Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis

JCO Oncology Practice(2022)10.1200/op.22.00037

N/A

0DataRank · unranked

27 citations

Diana Lin, Daniel R. Gomez, Jonathan T. Yang, Nancy Y. Lee, Andreas Rimner +19 more

Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process

Clinical and Translational Radiation Oncology(2022)10.1016/j.ctro.2022.04.009

N/A

0DataRank · unranked

7 citations

Noah J. Mathis, Max Vaynrub, Ernesto Santos Martin, Rupesh Kotecha, Joseph Panoff +16 more

Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.101096

N/A

0DataRank · unranked

3 citations

Gabriel Raab, Sean M. McBride, David G. Pfister, Richard J. Wong, Nancy Y. Lee +3 more

Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6089

N/A

0DataRank · unranked

10 citations

R. Michael Tuttle, Ravinder K. Grewal, Eric J. Sherman, Shrujal S. Baxi, Laura Boucai +14 more

Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity

Oral Oncology(2023)10.1016/j.oraloncology.2023.106400

N/A

0DataRank · unranked

7 citations

Heiko Schöder, Kaveh Zakeri, Linda Chen, Jung Julie Kang, Sean M. McBride +16 more

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1064

N/A

0DataRank · unranked

7 citations

Joris L. Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem, Maximilian Linxweiler +8 more

Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell–Like Carcinoma

Modern Pathology(2024)10.1016/j.modpat.2024.100674

N/A

0DataRank · unranked

7 citations

Mahmoud M. Elsayad, Maelle Saliba, Umesh Bhanot, Peter Ntiamoah, Anjanie Takeyama +14 more

Outcomes of SMARCB1‐deficient sinonasal carcinoma: Largest single‐center cross‐sectional study

Head & Neck(2024)10.1002/hed.27859

N/A

0DataRank · unranked

6 citations

Daniel W. Scholfield, Lucas Axiotakis, Conall Fitzgerald, Dauren Adilbay, Jennifer R. Cracchiolo +9 more

A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer

Oral Oncology(2024)10.1016/j.oraloncology.2024.106861

N/A

0DataRank · unranked

8 citations

David G. Pfister, Sarah Stein, Winston Wong, Eric J. Sherman, James Fetten +6 more

Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer

Oral Oncology(2025)10.1016/j.oraloncology.2025.107349

N/A

0DataRank · unranked

9 citations

Michael T. Starc, Richard J. Wong, Alan L. Ho, Ian Ganly, David G. Pfister +6 more

A phase II study of lenvatinib plus pembrolizumab in patients with recurrent/metastatic salivary gland cancers.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.6103

N/A

0DataRank · unranked

0 citations

Eric J. Sherman, Anuja Kriplani, James Fetten, Loren S. Michel, Michael Hwang +6 more

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa184

N/A

0DataRank · unranked

160 citations

Eric J. Sherman, Xin Pei, Heiko Schöder, Milan Grkovski, Ramesh Paudyal +38 more

A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Oral Oncology(2025)10.1016/j.oraloncology.2025.107524

N/A

0DataRank · unranked

0 citations

Alan L. Ho, Loren S. Michel, Winston Wong, Juliana Eng, Iris Zhi +9 more

Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas

Human Pathology(2020)10.1016/j.humpath.2020.08.004

N/A

0DataRank · unranked

28 citations

Paolo Cotzia, Ryan Ptashkin, Gouri J. Nanjangud, Bin Xu, Amir Momeni Boroujeni +7 more

Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6587

N/A

0DataRank · unranked

4 citations

Eric J. Sherman, Anuja Kriplani, Loren S. Michel, Lara Dunn, James Fetten +14 more